1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with niacin in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (niacin) | Trials (niacin) | Recent Studies (post-2010) (niacin) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 11,974 | 462 | 1,488 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | niacin (IC50) |
|---|---|---|---|
| Cholesteryl ester transfer protein | Homo sapiens (human) | 0.14 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 0.14 | |
| Hydroxycarboxylic acid receptor 2 | Homo sapiens (human) | 0.1726 | |
| Hydroxycarboxylic acid receptor 2 | Mus musculus (house mouse) | 0.14 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kwiterovich, PO | 1 |
1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and niacin
| Article | Year |
|---|---|
The antiatherogenic role of high-density lipoprotein cholesterol.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Anticholesteremic Agents; Aryldialkylphosphatase; Biological Transport; Biomarkers; Carrier Proteins; Cholesterol Esters; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Esterases; Humans; Incidence; Lipoproteins, HDL; Liver; Niacin; Phospholipases A; Platelet Activating Factor; Prognosis; Receptors, Lipoprotein; Risk Factors; RNA-Binding Proteins; Survival Rate | 1998 |